Clinical Trial to Evaluate the Safety and Efficacy of NTCB02-1 in Patients Who Require Parenteral Nutrition

PHASE3RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 4, 2024

Primary Completion Date

July 18, 2025

Study Completion Date

July 18, 2025

Conditions
Parenteral Nutrition
Interventions
DRUG

NTCB02-1

3 Days infusion

DRUG

NTCB-C

3 Days infusion

Trial Locations (5)

10408

RECRUITING

National Cancer Center, Gyeonggi-do

13620

RECRUITING

Seoul National University Bundang, Gyeonggi-do

54907

RECRUITING

Jeonbuk National University Hospital, Jeollabuk-do

58128

RECRUITING

Chonnam National University Hwasun Hospital, Jeollanam-do

03722

RECRUITING

Severance Hospital, Seoul

All Listed Sponsors
lead

Yuhan Corporation

INDUSTRY